Trial Profile
Fresolimumab and Radiotherapy in Metastatic Breast Cancer.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 27 May 2019
Price :
$35
*
At a glance
- Drugs Fresolimumab (Primary)
- Indications Advanced breast cancer
- Focus Therapeutic Use
- 21 Feb 2019 Status changed from active, no longer recruiting to completed.
- 14 Mar 2018 Planned End Date changed from 1 Jun 2017 to 1 Jun 2019.
- 23 Feb 2018 Results published in the Clinical cancer research: an official journal of the American Association for Cancer Research